LINDEN ADVISORS LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 21 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,466,026
-30.5%
43,274,000
-10.4%
0.35%
-32.1%
Q2 2023$49,616,921
+23.8%
48,274,000
+37.0%
0.52%
+23.5%
Q1 2023$40,079,804
+213.2%
35,247,000
+175.4%
0.42%
+214.9%
Q4 2022$12,795,060
+3.7%
12,800,000
+21.9%
0.13%
+18.6%
Q3 2022$12,335,000
+2263.0%
10,500,000
+2000.0%
0.11%
+2160.0%
Q2 2022$522,000500,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 25,000,000$26,265,0002.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 32,000,000$33,439,0000.69%
AQR Arbitrage LLC 28,460,000$29,840,0000.67%
WOLVERINE ASSET MANAGEMENT LLC 23,359,000$24,559,0000.25%
FRANKLIN RESOURCES INC 63,000,000$66,056,0000.03%
Citadel Advisors 86,490,000$90,901,0000.02%
KORNITZER CAPITAL MANAGEMENT INC /KS 600,000$626,0000.01%
LINDEN ADVISORS LP 500,000$522,0000.01%
BlackRock Inc. 2,925,000$3,052,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PTC THERAPEUTICS INC shareholders